Jeff Yass’s Kazia Therapeutics KZIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$740K Buy
77,102
+26,486
+52% +$332K ﹤0.01% 8728
2026
Q2
$713K Buy
+50,616
New +$617K ﹤0.01% 9058
2024
Q3
– Sell
-830
Closed -$16.6K – 12549
2024
Q2
$9.46K Buy
+830
New +$12.3K ﹤0.01% 11782
2022
Q2
– Sell
-501
Closed -$192K – 13470
2022
Q1
$192K Sell
501
-514
-51% -$184K ﹤0.01% 11284
2021
Q4
$429K Buy
1,015
+525
+107% +$262K ﹤0.01% 9577
2021
Q3
$281K Buy
490
+204
+71% +$100K ﹤0.01% 10744
2021
Q2
$141K Sell
286
-200
-41% -$105K ﹤0.01% 11888
2021
Q1
$301K Buy
+486
New +$254K ﹤0.01% 10598
2019
Q1
– Sell
-220
Closed -$25K – 9394
2018
Q4
$25K Sell
220
-2
-0.9% -$272 ﹤0.01% 8642
2018
Q3
$37K Buy
+222
New +$37.7K ﹤0.01% 8909

Other funds holding KZIA

Jeff Yass's KZIA Position: Q3 2026 in Review

Jeff Yass increased its Kazia Therapeutics (KZIA) stake by 52% in Q3 2026, buying an estimated $332K and bringing the position to 77,102 shares worth $740K. The position accounts for ﹤0.01% of the portfolio, ranked #8728.

Jeff Yass first reported a position in KZIA in Q3 2018 and has held it in 10 quarters since. 55 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

  • Jeff Yass held 77,102 shares of Kazia Therapeutics worth $740K as of Q3 2026.
  • Jeff Yass bought 26,486 Kazia Therapeutics shares in Q3 2026, an estimated $332K.
  • Kazia Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8728 holding.
  • Jeff Yass first reported a position in Kazia Therapeutics in Q3 2018 and has held it in 10 quarters since.
  • 55 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.